Baker Bros. Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Baker Bros. Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-112,897	Closed	-$13M	–	137
2020 Q4	$13M	Sell	112,897 -25,848	-19%	-$2.9M	0.05%	67
2020 Q3	$13.5M	Sell	138,745 -46,300	-25%	-$5.33M	0.05%	63
2020 Q2	$22.7M	Sell	185,045 -185,800	-50%	-$21.1M	0.1%	44
2020 Q1	$32.5M	Hold	370,845	–	–	0.2%	35
2019 Q4	$38.8M	Hold	370,845	–	–	0.21%	33
2019 Q3	$42.7M	Hold	370,845	–	–	0.29%	27
2019 Q2	$63.9M	Sell	370,845 -57,500	-13%	-$9.95M	0.43%	21
2019 Q1	$72.2M	Hold	428,345	–	–	0.46%	22
2018 Q4	$41.7M	Buy	428,345 +31,645	+8%	+$4.15M	0.34%	26
2018 Q3	$68.5M	Buy	396,700 +74,900	+23%	+$10.8M	0.45%	24
2018 Q2	$44.9M	Buy	321,800 +100,000	+45%	+$14.2M	0.34%	27
2018 Q1	$25M	Hold	221,800	–	–	0.21%	40
2017 Q4	$29.3M	Buy	221,800 +146,800	+196%	+$17.2M	0.25%	37
2017 Q3	$7.61M	Buy	+75,000	New	+$8.03M	0.06%	63
2016 Q3	–	Sell	-15,000	Closed	-$1.37M	–	138
2016 Q2	$1.37M	Hold	15,000	–	–	0.01%	109
2016 Q1	$1.08M	Buy	+15,000	New	+$823K	0.01%	116
2014 Q1	–	Sell	-94,172	Closed	-$3.91M	–	111
2013 Q4	$3.91M	Buy	+94,172	New	+$2.98M	0.06%	70

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baker Bros. Advisors's GWPH Position: Q1 2021 in Review

Baker Bros. Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 112,897 shares — an estimated $13M sold.

Baker Bros. Advisors first reported a position in GWPH in Q4 2013 and held it in 17 quarters. The position peaked at $72.2M in Q1 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Baker Bros. Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Baker Bros. Advisors sold 112,897 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $13M.
Baker Bros. Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 17 quarters.
Baker Bros. Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $72.2M in Q1 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Baker Bros. Advisors's 13F filing for Q1 2021, filed 17 May 2021.